Prospective population-based study of viral lower respiratory tract infections in children under 3 years of age (the PRI.DE study)

European Journal of Pediatrics
Johannes ForsterGudula Petersen

Abstract

Population-based incidence data from Europe on the disease burden of lower respiratory tract infections (LRTI) due to respiratory syncytial viruses (RSV), parainfluenza viruses (PIV) and influenzaviruses (IV) are lacking, especially with respect to the disease burden. In a 2-year prospective multicentre study of children aged <3 years in Germany, we registered population-based cases as outpatients (n=2386), inpatients (n=2924), and nosocomially-acquired (n=141). Nasopharyngeal secretions were tested for viral RNA. The annual incidence for physician visits per 100 children for all LRTI was 28.7, RSV 7.7, PIV 3.8 and IV 1.1. Annual hospitalisation rates per 10(5) children were for all LRTI 2941, RSV 1117, PIV 261 and IV 123. Annual nosocomial cases per 10(5) hospital days were for all LRTI 79, RSV 29, PIV 9 and IV 1.5. All five children (0.27%) who died had an underlying disease and four were nosocomially acquired. Hospitalisation rates due to lower respiratory tract infections in healthy children were similar to those reported elsewhere; the rates for outpatient visits were approximately ten times higher.

References

May 1, 1986·The Journal of Pediatrics·F W Denny, W A Clyde
Sep 1, 1982·American Journal of Public Health·J P Mullooly, W H Barker
Apr 1, 1994·Clinical Microbiology Reviews·R Vainionpää, T Hyypiä
Jun 3, 1999·The Journal of Infectious Diseases·R A KarronL H Harrison
Jan 29, 2000·The New England Journal of Medicine·K M NeuzilM R Griffin
Jan 29, 2000·The New England Journal of Medicine·H S IzurietaK Fukuda
May 12, 2000·American Journal of Respiratory and Critical Care Medicine·N SigursB Kjellman
Jul 18, 2000·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·J A WeiglH J Schmitt
Sep 15, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·C B Hall
Apr 28, 2001·Journal of Clinical Microbiology·S C KehlJ Fan
Jul 24, 2001·The Pediatric Infectious Disease Journal·M E CounihanL J Anderson
Sep 20, 2001·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·J A WeiglH J Schmitt
Jan 25, 2002·The Journal of Infectious Diseases·Kathleen M NeuzilPeter F Wright
Mar 15, 2002·The Lancet Infectious Diseases·Brian G WilliamsChristopher Dye
Apr 10, 2002·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·A G ConstantopoulosM L Marcopoulos
May 10, 2002·Pediatric Pulmonology·Martin C J KneyberHenriëtte A Moll
Jun 26, 2002·Public Health·N R Holmes, C M Ni Bhrolchain
Dec 27, 2002·The New England Journal of Medicine·Susan S ChiuJ S Malik Peiris
Feb 1, 2003·Epidemiology and Infection·J A I WeiglH J Schmitt
Apr 15, 2003·Clinical Microbiology Reviews·Kelly J Henrickson

❮ Previous
Next ❯

Citations

Jun 21, 2005·European Journal of Pediatrics·Birgit EhlkenUNKNOWN PRIDE Study Group
Oct 28, 2008·Archives of Virology·Beena MailaparambilAndrea Heinzmann
Nov 29, 2007·The Pediatric Infectious Disease Journal·Beena PuthothuAndrea Heinzmann
Mar 10, 2011·The Pediatric Infectious Disease Journal·Bernhard ReschWilhelm Müller
Nov 15, 2011·Journal of Paediatrics and Child Health·Hannah C MooreDeborah Lehmann
Jan 13, 2010·Clinical Microbiology Reviews·John S Tregoning, Jürgen Schwarze
Oct 16, 2008·Clinical Microbiology Reviews·James B Mahony
Oct 9, 2004·Journal of Clinical Microbiology·Brigitte KönigJohannes Forster
Nov 3, 2006·Journal of Virology·Krzysztof PyrcLia van der Hoek
Apr 23, 2011·BMC Infectious Diseases·Molly LeecasterMatthew Samore
Dec 15, 2012·BMC Infectious Diseases·Caroline F ShafikFouad G Youssef
Jan 19, 2012·BMC Infectious Diseases·Jamal A AhmedRachel B Eidex
Apr 2, 2005·BMC Infectious Diseases·Elena Terletskaia-LadwigMartin Enders
Mar 1, 2006·Clinical and Molecular Allergy : CMA·Beena PuthothuAndrea Heinzmann
Aug 18, 2005·PLoS Medicine·Lia van der HoekKlaus Uberla
Jan 19, 2013·American Journal of Public Health·W Paul GlezenJohn Oxford
Aug 12, 2010·The Open Virology Journal·Sahar Abdul-Rasool, Burtram C Fielding
Mar 4, 2011·Future Microbiology·Burtram C Fielding
Oct 19, 2007·European Journal of Pediatrics·Arne SimonUNKNOWN DSM RSV Paed Study Group
Feb 24, 2006·Archives of Disease in Childhood. Fetal and Neonatal Edition·H L A Van RostenbergheM J M Hanifah
Aug 24, 2011·Expert Review of Respiratory Medicine·Alexander C SchmidtPeter L Collins
Jan 4, 2013·Paediatric Respiratory Reviews·Shelagh M SzaboAdrian R Levy
Mar 30, 2010·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Lia van der HoekKlaus Uberla
Jan 23, 2009·The Journal of Pediatrics·Geoffrey A WeinbergUNKNOWN New Vaccine Surveillance Network
Apr 15, 2008·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·T P SlootsM D Nissen
Jan 31, 2008·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·William F Carman, James B Mahony
Aug 11, 2007·Journal of Clinical Epidemiology·G IhorstM Schumacher
Aug 9, 2006·International Journal of Immunogenetics·M KruegerA Heinzmann
Sep 25, 2008·Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology·Beena PuthothuAndrea Heinzmann
Nov 24, 2006·Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology·Beena PuthothuAndrea Heinzmann
May 16, 2006·International Journal of Hygiene and Environmental Health·Arne SimonUdo Bode
Aug 17, 2006·FEMS Microbiology Reviews·Lia van der HoekBen Berkhout
Jun 20, 2012·Current Opinion in Virology·Henrick SchomackerAlexander C Schmidt

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies
S C BuckinghamJ P DeVincenzo
The New England Journal of Medicine
Kenneth McIntosh
© 2021 Meta ULC. All rights reserved